Maples and Calder advised Biohaven Pharmaceutical Holding Company Ltd on the British Virgin Islands legal aspects of the deal. The transaction involved a US$500 million non-dilutive…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
